NTRA Q1 2023 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$29B

Q1 2023 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$242M+24.5% YoY

Gross Profit

$94M38.7% margin

Operating Income

-$138M-57.2% margin

Net Income

-$137M-56.6% margin

EPS (Diluted)

$-1.23

QoQ Revenue Growth

+11.3%

Cash Flow

Operating Cash Flow

-$81M

Free Cash Flow

-$92M

Stock-Based Comp.

$40M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$668M

Stockholders' Equity

$651M

Cash & Equivalents

$403M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$242M	$194M	+24.5%
Gross Profit	$94M	$91M	+3.0%
Operating Income	-$138M	-$137M	-0.9%
Net Income	-$137M	-$139M	+1.2%

Revenue Segments

Product

$238M98%

Licensing and other

$4M2%

Royalty

$600,0000%

Geographic Segments

United States

$233M96%

Europe, Middle East, India, Africa

$5M2%

Asia Pacific and Other

$2M1%

Americas, excluding U.S.

$1M0%